Philip M.W. Bath

Learn More
AIMS Randomized controlled trials (RCTs) have shown that the risk of stroke and venous thromboembolism (VTE) is increased with hormone replacement therapy (HRT); the effect on coronary heart disease (CHD) remains unclear. METHODS AND RESULTS RCTs of HRT were identified. Event rates for cerebrovascular disease [stroke, TIA (transient ischaemic attack)],(More)
Hypertension is a major risk factor for stroke disease. There is now some international agreement on what constitutes hypertension, and at what level of blood pressure treatment is required. Large randomised controlled trials demonstrate the benefit of reducing blood pressure for the primary and secondary prevention of stroke disease. Studies have also(More)
Laura J. Gray, Nikola Sprigg, Philip M.W. Bath, Gudrun Boysen, Peter Paul De Deyn, Didier Ischaemic Stroke Trial (TAIST) Sex Differences in Quality of Life in Stroke Survivors: Data From the Tinzaparin in Acute Print ISSN: 0039-2499. Online ISSN: 1524-4628 Copyright © 2007 American Heart Association, Inc. All rights reserved. is published by the American(More)
  • 1